Latest Updates on ABBV
-
Cannabis There's Still Some Time to Move on This Must-Own Biotech
Some market-leading biotech firms are working hard right now developing drugs derived from cannabis' many beneficial compounds.And there's one innovative company that puts you right in the middle of the sector's market-crushing … Read more » -
Trading Strategies Here Are Three of My Favorite Dividend Plays - Including One with a 7.4% Yield
Our Shah Gilani calls this time "The Era of the Income-Challenged Investor." And with good reason. Fed policymakers just voted to keep benchmark short-term interest rates down near zero and they're likely to stay there until … Read more » -
Stocks The 5 Best High-Yield Dividend Stocks to Buy in This Bear Market
High-yield dividend stocks typically carry some risk, but the devastating impact of the coronavirus on the economy has upset an otherwise sound strategy. Many companies that were thriving before the crisis have trimmed or suspended their … Read more » -
Stocks 3 Blue-Chip Dividend Stocks to Hedge Your Portfolio
The Dow Jones Industrial Average is coming off its sharpest drop into a bear market in history this month. The ongoing coronavirus response has effectively shut down the hospitality, travel, and restaurant industries. With that in … Read more » -
Trading Strategies The Two Things to Do When the Dow Falls 500 Points
My colleague Keith Fitz-Gerald told you yesterday how we could see a 3% to 5% market drop as more coronavirus news comes out. The Dow's lost about 1.8% since Friday. Usually this week we'd be diving into earnings-related … Read more » -
stocks The 3 Best Dividend Stocks to Buy Now All Yield Over 4%
If you're an income-seeking investor trying to maximize returns, the best dividend stocks to buy could be your ticket. Read more » -
Dow Jones The Dow Jones Today Will Be Flat Ahead of Fed Chair Powell's Speech
The Dow Jones today is heading for a flat morning as traders wait to hear from Federal Reserve Chair Jerome Powell. The head of the U.S. central bank is expected to discuss his outlook on the U.S. economy and the road ahead for interest … Read more » -
Stocks 3 High-Yield Dividend Stocks to Buy Now
Investors seeking to buy high-yield dividend stocks need to know where to look. With market conditions mimicking pre-recession - an inverted yield curve, debts, and late payments on the rise - profiting from dividends looks more and more … Read more » -
Stocks The 3 Best Dividend Stocks to Buy in February 2019
Investors are always seeking the secret weapon to help them achieve life-changing gains. You can search forever for new strategies, but the truth the best system to find these types of gains is right in front of you. Read more » -
Economic Data This Record-Setting Stock Trend Could Deliver Your Next Big Winner
The financial news networks have their hands full. That's why today, I want to talk to you about something they're missing... You see, the buyback corner of the market has been serving up record-breaking numbers lately. Now, … Read more » -
IPOs Forget the Lyft IPO - Buy This Stock Instead
Eager investors are hoping the Lyft IPO will be their next opportunity for market-beating gains this year. Unfortunately, you won't be able to invest in Lyft stock right now because the IPO hasn't happened yet. Read more » -
stocks The 3 Best Biotech Stocks to Buy in June 2018
By 2025, the biotech industry will be worth will be $727 billion - a 120% increase over its total value in 2015. To help you take advantage of the tremendous gains in biotech stocks, we're bringing you the three best biotech stocks to buy … Read more » -
Stocks This Secret Method Just Uncovered One Stock You Need to Buy Now
Stocks have been flat this year, but that doesn't mean sharp traders aren't making money hand over fist. After all, we're still in the middle of the second-longest bull market ever. And you can be one those traders raking in money while … Read more » -
Stocks The 3 Best Biotech Stocks to Buy Today
Since hitting a high in late January, the iShares Nasdaq Biotechnology ETF has slumped more than 11%. But that doesn't mean investors should stop looking for the best biotech stocks to buy today. You see, the slump in biotech stocks has … Read more » -
Stocks Why AbbVie Is Still a Stock to Buy After Last Week's Plunge
AbbVie Inc., a biotech stock we like, took a hit last week following disappointing mid-phase trial results for one of its pipeline drugs. We see no reason to change our recommendation: This stock is still poised for long-term growth. Read more »
